Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 188-192

  Dhakal, Sughosh ^a   Biswas, Tithi ^a   Liesveld, Jane L ^a   Friedberg, Jonathan W ^a   Phillips, Gordon L ^a   Constine, Louis S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Autologous stem cell transplantation; High dose chemotherapy; Hodgkin's lymphoma; Local disease recurrence; Relapse

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; HODGKIN'S LYMPHOMA; LOCAL DISEASE RECURRENCE; RELAPSE;

CELL MEMBRANES; CHEMOTHERAPY; TIME MEASUREMENT;

DIAGNOSIS;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS; YOUNG ADULT;

EID: 68649112844     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.048     Document Type: Article

References (16)

1. Hasenclever D., and Diehl V. International prognostic factors project on advanced Hodgkin's disease: A prognostic score for advanced Hodgkin's disease. N Engl J Med 339 (1998) 1506-1514
2. Mauch P., Kalish L., Marcus K., et al. Long-term survival in Hodgkin disease: Relative impact of mortality, secondary tumor, infection and cardiovascular disease. Cancer J Sci Am 1 (1995) 33-42
3. Aleman B.M., van den Belt-Dusebout A.W., Klokman W.J., et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21 (2003) 3431-3439
4. Bhatia S., Robison L., Oberlin O.L., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
5. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting advanced mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
6. Mauch P. Second malignancies after curative radiation therapy for good prognosis cancers. Int J Radiat Oncol Biol Phys 33 (1995) 959-960
7. Ng K., Bernardo M.P., Weller E., et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20 (2002) 2101-2108
8. Leeuwen F.E., Klokman W.J., Stovall M., et al. Role of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2000) 971-980
9. Engert A., Schiller P., Josting A., et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavourable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21 (2003) 3601-3608
10. Ferme C., Eghbali H., Hagenbeek A., et al. MOPP/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I-II Hodgkin's disease: Comparison of three treatment modalities: Preliminary results of the EORTC-GELA H8U randomized trial in 995 patients. Blood 96 (2000) A576
11. Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkins lymphoma: Concepts and guidelines. Radiother Oncol 79 (2006) 270-277
12. Shahidi M., Kamangari N., Ashley S., et al. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease. Radiother Oncol 78 (2006) 1-5
13. Roach M., Brophy N., Cox R., et al. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. J Clin Oncol 8 (1990) 623-629
14. Horwich A., Specht L., and Ashley S. Survival analysis of patients with clinical stages I or II Hodgkin's disease who have relapsed after initial treatment with radiotherapy alone. Eur J Cancer 33 (1997) 848-853
15. Brice P., Bastion Y., Divine M., et al. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Cancer 78 (1996) 1293-1299
16. Healey E.A., Tarbell N.J., Kalish L.A., et al. Prognostic factors for patients with Hodgkin disease in first relapse. Cancer 71 (1993) 2613-2620